SDSC joins other UC San Diego departments, LLNL in oncology collaboration

January 26, 2010

Researchers from the San Diego Supercomputer Center (SDSC) at UC San Diego have joined forces with the Department of Radiation Oncology in the university's School of Medicine, its Department of Mathematics, and the Lawrence Livermore National Laboratory (LLNL) in a three-year, $1.5 million project to pursue novel applications of high-performance computing (HPC) in radiotherapy.

Under the project, called SCORE for SuperComputing Online Re-planning Environment, SDSC researchers are collaborating with oncology researchers to redesign treatment plans leveraging HPC resources and expertise. The project was awarded from a University of California Office of the President grant based on the Lab Fees Research Program in 2009.

The ultimate goal of the proposed HPC-based radiation therapy, specifically referred to as 'Adaptive Radiation Therapy (ART) Based on High-Performance Computing,' is to deliver a prescribed radiation dose to targets containing tumors and cancerous regions, while sparing surrounding functional organs and normal tissues. Currently, these regions are treated using a so-called "optimal" treatment plan that is based on patient geometry acquired via imaging prior to commencement of a sequence of 25 to 40 daily treatments administered during a time span of five and eight weeks.

"This current treatment paradigm therefore implicitly assumes that the patient is static and ignores the fact that tumor and nearby organs are mobile and distensible, so that their position and shape may vary substantially from day to day, and that there is significant dynamic change in tumor geometry in response to the radiotherapy," said Steve Jiang, associate professor and executive director for the Center for Advanced Radiotherapy Technologies (CART), the research arm of the Department of Radiation and Oncology at UC San Diego's School of Medicine, and director of the SCORE project. "As a result, the quality of the current treatment plans may deteriorate during their course."

The biggest challenge for the proposed HPC-based radiation therapy is the real-time requirement of performing three computationally intensive tasks: patient modeling based on deformable image registration, radiation transport simulation and dose calculation using Monte Carlo methods, and treatment optimization as a large scale optimization problem.

"Traditional HPC platforms, due to the difficulty in availability to general clinical users and real-time accessibility, are not suitable for real-time re-planning treatment while the patient is lying under the treatment machine waiting for radiation treatment," said Amit Majumdar, head of the Scientific Computing Applications Group at SDSC, and a newly named associate professor in the Department of Radiation Oncology at UC San Diego's School of Medicine.

In the first phase of the project, the research group is exploring the use of graphics processing units (GPUs) as the parallel computing framework for real-time re-planning. Many of the algorithms and codes have been modified and implemented efficiently on GPUs. To date, this work has resulted in three peer-reviewed journal papers for CART, and additional submissions are under review.

The team's work is already receiving attention from the field of cancer therapy. "We now can perform a re-planning procedure within 10 seconds, while the current state of the art takes dozens of minutes," said Jiang. "Our work shows that online adaptive radiotherapy is possible, and that it has much promise as the next generation of technology for cancer radiotherapy, with great potential to improve local tumor control and reduce toxicities by adapting the treatment to the varying patient anatomy."

The research group is also focusing on developing a comprehensive prototype hardware and software environment integrating GPUs, radiotherapy codes, and clinically efficient graphical user interfaces (GUI) that medical professionals can use in a real clinical environment for patient treatment. Initially, this will be used for patient treatment in a research environment with potential for full clinical implementation in the near future.
Researchers, in addition to Jiang and Majumdar, include Dong Ju Choi, a senior computational scientist at SDSC and also a newly appointed assistant professor in the university's Department of Radiation Oncology, who along with Majumdar is involved in collaborating on the HPC part of the project. Marie-Anne Descalle's group at LLNL is providing expertise in Monte Carlo simulation of radiation transport and dose calculation. Mike Holst, from UC San Diego's Department of Mathematics, is collaborating in the development and implementation of the algorithms.

Also participating in this research are postdoctoral researchers Xuejun Gu, Chunhua Men, Xun Jia, Franck Vidal, and Oliver Fluck, all from the Department of Radiation Oncology at UC San Diego's School of Medicine; and undergraduate student Michael Folkerts from UC San Diego's Physics Department.

About SDSC

As an organized research unit of UC San Diego, SDSC is a national leader in creating and providing cyberinfrastructure for data-intensive research. Cyberinfrastructure refers to an accessible and integrated network of computer-based resources and expertise, focused on accelerating scientific inquiry and discovery. SDSC recently doubled its size to 160,000 square feet with a new, energy-efficient building and data center extension, and is a founding member of TeraGrid, the nation's largest open-access scientific discovery infrastructure.

About CART

The Center for Advanced Radiotherapy Technologies (CART) is the research arm of the Department of Radiation Oncology in UC San Diego's School of Medicine. CART is committed to innovating and clinically testing new technological approaches to radiation therapy. To accomplish this, research efforts are integrated from many scientific disciplines, including medicine, medical physics, engineering, mathematics, computer science, and biology, to translate technological innovations from the laboratory to the clinic. CART provides an infrastructure to promote strong and unique collaborations between investigators from various disciplines, resulting in a seamless adoption of new technologies into routine clinical practice.

University of California - San Diego

Related Radiotherapy Articles from Brightsurf:

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas in NRG Oncology clinical trial
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.

Outcomes in radiotherapy-treated patients with cancer during COVID-19
The delivery of radiotherapy in 209 patients with cancer during the COVID-19 outbreak in Wuhan, China, is evaluated in this case series.

Shorter radiotherapy treatment for bowel cancer patients during COVID-19
An international panel of cancer experts has recommended a one-week course of radiotherapy and delaying surgery as the best way to treat patients with bowel cancer during the COVID-19 pandemic.

The pros and cons of radiotherapy: Will it work for you?
Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia's most experienced radiation oncology medical physicists.

How to keep boron inside cells during radiotherapy: a novel approach to cancer treatment
Boron neutron capture therapy (BNCT) is a technique in which p-boronophenylalanine (BPA) is transferred to cancer cells, and the boron in it undergoes nuclear fission reaction upon irradiation of thermal neutrons, releasing high energy particles that kill the cells.

Prolonged breath-holding could help radiotherapy treatment of cardiac arrhythmias
A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.

Zebrafish 'avatars' can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients.

One dose of radiotherapy as effective as five doses for cancer in the spine
A single dose of radiotherapy is as 'effective' as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

Personalized and powerful: UK to lead next-generation radiotherapy research
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today.

Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows.

Read More: Radiotherapy News and Radiotherapy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to